| Current Price | $2.50 | Mkt Cap | $91.3M |
|---|---|---|---|
| Open | $2.51 | P/E Ratio | -1.20 |
| Prev. Close | $2.50 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $2.46 - $2.55 | Volume | 356,904 |
| 52-Wk Range | $1.15 - $3.84 | Avg. Daily Vol. | 1,879,608 |
| Current Price | $2.50 | Mkt Cap | $91.3M |
|---|---|---|---|
| Open | $2.51 | P/E Ratio | -1.20 |
| Prev. Close | $2.50 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $2.46 - $2.55 | Volume | 356,904 |
| 52-Wk Range | $1.15 - $3.84 | Avg. Daily Vol. | 1,879,608 |
The best Bull and Bear pitches based on recency and number of recommendations.
I get caught up in these biotechs with tiny market caps and huge products. Brexafemme has aced it's trials and seems likely to be approved. If approved it only needs to have sales of $30-40 million to support its current market cap. In a $1billion+… More
Can't believe they perfected the motel experience after just 6 tries.
Read the most recent pitches from players about SCYX.
Recs
TMFSecurity
(93.16)
Submitted: 11/16/2021 8:31:12 AM :
Start Price:
$7.06
NASDAQ:SCYX Score:
+53.93
10000000146
Recs
odocoileus
(37.62)
Submitted: 5/2/2021 12:13:48 AM :
Start Price:
$7.47
NASDAQ:SCYX Score:
-66.47
I get caught up in these biotechs with tiny market caps and huge products. Brexafemme has aced it's trials and seems likely to be approved. If approved it only needs to have sales of $30-40 million to support its current market cap. In a $1billion+ market it seems like a low bar, with the potential of a 5-10 bagger if things really work out. However I've seen these small companies get crushed by the bohemoths that don't like the competition. Hopefully swatting this insect is messier than a simple buyout.
Find the members with the highest scoring picks in SCYX.
RTChokies (98.84) Score: +879.15
The Score Leader is the player with the highest score across all their picks in SCYX.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| KaivalyaKavya | < 20 | 9/10/2020 |
|
5Y | $0.72 | +247.71% | +22.09% | +225.61 | 0 Comment | |
| clevefan95 | < 20 | 4/13/2020 |
|
3Y | $0.87 | +187.36% | +50.47% | +136.89 | 0 Comment | |
| JoeySolitro3 | 99.52 | 12/19/2016 |
|
5Y | $3.36 | -25.60% | +84.84% | +110.43 | 0 Comment | |
| RTChokies | 98.84 | 3/2/2021 |
|
5Y | $8.93 | -71.99% | +7.66% | +79.65 | 0 Comment | |
| RANEsq | 64.72 | 11/17/2020 |
|
5Y | $5.86 | -57.34% | +15.94% | +73.28 | 0 Comment | |
| whatsthepoint | 99.99 | 11/17/2020 |
|
5Y | $5.86 | -57.34% | +15.94% | +73.28 | 0 Comment | |
| TMFSecurity | 93.16 | 11/16/2021 |
|
NS | $7.06 | -64.59% | -10.66% | +53.93 | 1 Comment | |
| WildShaman | 77.00 | 7/9/2018 |
|
5Y | $1.80 | +38.89% | +50.91% | +12.02 | 0 Comment | |
| efarev | 36.29 | 2/5/2018 |
|
5Y | $1.75 | +42.86% | +52.62% | -9.76 | 0 Comment | |
| Playa17 | < 20 | 10/5/2022 |
|
5Y | $2.48 | +0.81% | +11.77% | -10.96 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
